Cargando…
Arsenic trioxide inhibits EBV reactivation and promotes cell death in EBV-positive lymphoma cells
BACKGROUND: Epstein-Barr Virus (EBV) is associated with hematopoietic malignancies, such as Burkitt’s lymphoma, post-transplantation lymphoproliferative disorder, and diffuse large B-cell lymphoma. The current approach for EBV-associated lymphoma involves chemotherapy to eradicate cancer cells, howe...
Autores principales: | Yin, Qinyan, Sides, Mark, Parsons, Christopher H., Flemington, Erik K., Lasky, Joseph A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480106/ https://www.ncbi.nlm.nih.gov/pubmed/28637474 http://dx.doi.org/10.1186/s12985-017-0784-7 |
Ejemplares similares
-
Co-treatment with arsenic trioxide and ganciclovir reduces tumor volume in a murine xenograft model of nasopharyngeal carcinoma
por: Sides, Mark D, et al.
Publicado: (2013) -
Inhibition of autophagy in EBV-positive Burkitt's lymphoma cells enhances EBV lytic genes expression and replication
por: De Leo, A, et al.
Publicado: (2015) -
Increasing the purity, potency and specificity of ebv-specific T cells to improve the treatment of EBV-positive lymphoma
por: Sharma, Sandhya, et al.
Publicado: (2015) -
EBV-positive Reactive Hyperplasia Progressed into EBV-positive Diffuse Large B-cell Lymphoma of the Elderly over a 6-year Period
por: Kunitomi, Akane, et al.
Publicado: (2017) -
EBV & lymphoma
por: Caballero, Dolores
Publicado: (2019)